State senators in Kentucky and Georgia advanced bills this week that would enact steeper restrictions on hemp products.
Senate Bill 202 cleared a Kentucky Senate committee after the inclusion of a ban on all low-dose THC hemp-derived beverages until the summer of 2026.
Hemp-derived beverages have been sold in Kentucky for two-plus years, including at liquor stores, according to Louisville Public Media.
Buyers must be at least 21 years old.
Meanwhile, Georgia lawmakers are weighing three proposals regarding hemp and medical marijuana.
According to the Atlanta-based Georgia Recorder:
- Senate Bill 33 would strengthen consumer protections by requiring testing and labeling regulations for products with delta-8 THC, delta-10 THC, hexahydrocannabinol (HHC) and other cannabinoids.
- Senate Bill 254, which was amended to ban all THC-infused beverages, also would place new restrictions on hemp-derived delta-8 and delta-10.
- Senate Bill 220 seeks to expand the state’s rather restrictive medical marijuana program by easing access – specifically, removing “severe or end-stage” as a prerequisite to approve patients with cancer, Parkinson’s and other illnesses.
The legislation also aims to:
- Eliminate a ban on vaping products.
- Raise THC limits from 5% to 50%.
- Add lupus as a qualifying condition.
- Replace the term “low-THC oil” with “medical cannabis.”
Medical Disclaimer:
The information provided in these blog posts is intended for general informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. The use of any information provided in these blog posts is solely at your own risk. The authors and the website do not recommend or endorse any specific products, treatments, or procedures mentioned. Reliance on any information in these blog posts is solely at your own discretion.
